Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Nothing enters your body
Future studies should aim to define tolerance thresholds and identify predictors of adherence, while future guidelines should incorporate tolerability data alongside efficacy in recommending GLP-1 RAs for this expanding patient population
Several factors influence how quickly results appear
To summarize, on one hand the modest upwards trajectory of the obese and diabetic population provides a fertile ground for Pharma companies to sell more for the years to come, however, downside risks remain, including: pricing, compounders and overall competition, which will make it hard for companies like Novo and Lilly to maintain their growth
The six-vial option has the lowest listed price per vial for each size
US$ 23.67
US$ 20.13
US$ 24.82
US$ 26.13
US$ 28.34
US$ 29.12
US$ 29.42
US$ 21.70
